Crescent BiopharmaNASDAQ: CBIO: Develops novel oncology therapies and antibody-drug conjugates for cancer.
12+ YOERequires a degree in a relevant scientific or engineering field and 12+ years in drug product development, MSAT, and external CDMO manufacturing, with biologics, ADC, GMP, regulatory, and leadership expertise.
Xenon PharmaceuticalsNASDAQ: XENE: Developing therapeutics for neurological and psychiatric disorders.
10+ YOEPhD in Chemistry or Chemical Engineering with 10+ years API CDMO experience; regulatory CMC writing; CDMO selection and tech transfer; extensive cGMP knowledge.
Director, Peptide Process Development (Cambridge, MA, US, 02142)
Cambridge, Massachusetts, United States
$197k-$267k/yrOnsiteFull Time
AlnylamNasdaq: ALNY: Developing and commercializing RNA interference (RNAi) therapeutics for diseases.
10+ YOEPhD with 10+ years in peptide or conjugate process development; experience leading CDMO collaborations and GMP manufacturing; strong regulatory documentation experience.
Dyne TherapeuticsNASDAQ: DYN: Developing therapeutics for genetically driven neuromuscular diseases.
10+ YOE10+ years biopharma experience in biologics process development, CDMO management, CMC strategy, regulatory authoring (Module 3), and leadership in a matrixed environment.
Senior Director, Analytical Development and Quality Control
Somerville, Massachusetts, United States
$210k-$300k/yrRemoteFull Time
Generate BiomedicinesNasdaq: GENB: Generates novel protein therapeutics using machine learning and generative biology.
15+ YOEPh.D. or M.S. with significant experience; 15+ years in analytical development and QC for biologics, leadership of analytical organizations, GMP expertise, regulatory submissions, and CDMO management.
Kymera TherapeuticsNASDAQ: KYMR: Develops targeted protein degradation medicines to treat human diseases.
15+ YOEPhD and 15+ years pharmaceutical experience in early-stage formulation development, expertise in preformulation, biopharmaceutics, enabling technologies, GMP/regulatory knowledge, and CRO/CDMO management.
Vertex PharmaceuticalsNASDAQ: VRTX: Develops and sells prescription drugs for serious genetic diseases.
10+ YOE10+ years sourcing/CDMO experience in pharmaceuticals, strong negotiation and supplier management, leadership and team development, contract and risk management, analytical skills, familiarity with GMP and regulatory standards.
LonzaSIX Swiss Exchange: LONN: Manufactures medicines and provides development services for healthcare companies.
8+ YOEBachelor's degree in a relevant field and 8+ years in biotechnology, pharmaceutical, CDMO, or life sciences business development, sales, account management, or commercial leadership. Salesforce and Microsoft Office proficiency required.
Sr. Business Development Executive - Biotech Solutions (New England)
Boston, Massachusetts, United States
$128k-$192k/yrRemoteFull Time
Thermo Fisher ScientificNYSE: TMO: Sells equipment and chemicals for scientific research and healthcare.
5+ YOE5+ years quota-carrying field sales or business development in CDMO services; hunter mindset; proven new logo wins and multi-year contracts; willing to travel up to 50%.
Associate Director, Analytical Development & Quality Control
Boston, Massachusetts, United States
OnsiteFull Time
Alpha-9 Oncology: Developing targeted radiopharmaceuticals for the treatment of cancer
8+ YOE5+ MgmtPh.D. with ≥8 years or M.S. with ≥11 years in analytical chemistry/radiochemistry; ≥5 years managing CDMOs; experience with analytical method lifecycle, investigations, OOS/OOT, CAPA, and cGMP/ICH requirements.
Director, Drug Substance Manufacturing & Development
United States or Waltham or Boulder
$210k-$240k/yrRemoteFull Time
Cogent BiosciencesNASDAQ: COGT: Develops precision therapies for genetically defined diseases
8+ YOEDegree in organic chemistry with extensive small-molecule drug substance and cGMP experience, demonstrated CDMO management, ICH Q7 knowledge, solid-state characterization experience, and ability to travel 10–30%.
Viridian TherapeuticsNASDAQ: VRDN: Developing optimized treatments for rare autoimmune conditions.
5+ YOE5+ years QA experience in biotech/pharma/medical device, Bachelor's in Life Science or Engineering, complaint handling, experience with CDMOs, Veeva eQMS, knowledge of US/global GMP and ICH guidelines.
Veeva Quality Management System, Microsoft Word, Microsoft PowerPoint, Microsoft Excel, Microsoft Outlook, Microsoft SharePoint
AlkermesNASDAQ: ALKS: Develops medicines for psychiatric and neurological disorders.
PhD (>8 yrs) or MS (>15 yrs) in Science/Engineering; expert in small-molecule process development, scale-up, tech transfer, DOE, data analysis, CDMO management; strong leadership and communication.
Head of Chemistry, Manufacturing, and Controls (CMC)
Boston or United States
RemoteFull Time
Voisin Consulting Life Sciences: Global consultancy guiding life science products from discovery to patients.
Degree in a relevant scientific discipline, significant CMC and drug development experience across biologics, oligonucleotides, combination products, and cell & gene therapies; team leadership, regulatory submission and GMP knowledge, CDMO experience.
Sr. Manager / Associate Director, Late-Phase Drug Substance PD/MSAT
Cambridge, Massachusetts, United States
$165k-$200k/yrOnsiteFull Time
Merida Biosciences: Developing precision therapeutics for autoimmune and allergic diseases.
5+ YOEPh.D. plus 5+ years or M.S. plus 8+ years in upstream biologics industry experience; expertise in fusion proteins, bioreactors, process characterization, PPQ, CMC filings, statistical modeling, and CDMO management.
Rentschler Biopharma: Provides biopharmaceutical contract development and manufacturing services.
15+ YOEUniversity degree in communications/journalism/marketing/life sciences, 15+ years PR/media/corporate communications in pharma/biotech/CDMO, executive and crisis communications experience, proven media relationships, German and English fluency.
Associate Director, Drug Substance & Manufacturing (Late-Stage)
Boston, Massachusetts, United States
$190k-$210k/yrHybridFull Time
Rapport TherapeuticsNASDAQ: RAPP: Developing precision medicines for neurological and psychiatric disorders.
8+ YOEM.S. or Ph.D. in Process/Organic Chemistry or Chemical Engineering; 8+ years (Ph.D.) or 10+ years (M.S.) in small-molecule drug substance development; experience with DoE, CPV, CDMOs, and ICH guidance for late-stage/registration.
DoE, CPV, ICH Q7-Q12, ICH Q3A, ICH Q3C, ICH Q3D, ICH M7, NDA, MAA
Catalent: Global provider of drug development and manufacturing solutions.
3+ YOEBachelor's degree, minimum 3 years commercial/account management or related client-facing experience in manufacturing/CDMO/pharma; forecasting/SIOP experience; Microsoft Office and ERP proficiency; strong communication and cross-functional collaboration.
Relay TherapeuticsNASDAQ: RLAY: Develops precision medicines by analyzing dynamic protein motion.
5+ YOEPhD and 5+ years in process development/tech transfer/manufacturing for small-molecule APIs; expertise in synthetic organic chemistry, cGMP/ICH/FDA/EMA expectations, analytical techniques, scientific writing, and CRO/CDMO collaboration.
NMR, IR, mass spectroscopy, ReactIR, UV/Vis, HPLC, GC, TLC, flash chromatography, PAT